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Protein tyrosine phosphatase 1B (PTP1B) is a negative regu-
lator of insulin signaling and a therapeutic target for type 2
diabetes. The purpose of this study was to evaluate the dif-
ferences in insulin sensitivity between neonate and adult
hepatocytes lacking PTP1B. Immortalized neonatal hepato-
cytes and primary neonatal and adult hepatocytes have been
generated from PTP1B/ and wild-type mice. PTP1B defi-
ciency in immortalized neonatal hepatocytes prolonged insu-
lin-induced tyrosine phosphorylation of the insulin receptor
(IR) and IR substrates (IRS) -1, -2 compared with wild-type
control cells. Endogenous IR and IRS-2 were down-regulated,
whereas IRS-1 was up-regulated in PTP1B/ neonatal hepa-
tocytes and livers of PTP1B/ neonates. Insulin-induced ac-
tivation of phosphatidylinositol 3-kinase/Akt pathway was
prolonged in PTP1B/ immortalized neonatal hepatocytes.
However, insulin sensitivity was comparable to wild-type
hepatocytes. Rescue of PTP1B in deficient cells suppressed
the prolonged insulin signaling, whereas RNA interference in
wild-type cells promotedprolonged signaling. Inprimaryneo-
natal PTP1B/ hepatocytes, insulin prolonged the inhibition
of gluconeogenicmRNAs, but the sensitivity to this inhibition
was similar to wild-type cells. By contrast, in adult PTP1B-
deficient livers, p85was down-regulated compared with the
wild type. Moreover, primary hepatocytes from adult
PTP1B/mice displayed enhanced Akt phosphorylation and
a more pronounced inhibition of gluconeogenic mRNAs than
wild-type cells. Hepatic insulin sensitivity due to PTP1B de-
ficiency is acquired through postnatal development. Thus,
changes in IR and IRS-2 expression and in the balance be-
tween regulatory and catalytic subunits of phosphatidylino-
sitol 3-kinase are necessary to achieve insulin sensitization in
adult PTP1B/ hepatocytes. (Endocrinology 148: 594–608,
2007)
INSULIN RESISTANCE IN insulin target tissues such asliver, adipose tissues, and skeletal muscle is a key patho-
genic feature of type 2 diabetes. Among them, hepatic insulin
resistance is considered to be a dominant component in the
pathogenesis of fasting hyperglycemia in type 2 diabetes (1,
2). The molecular mechanism underlying hepatic insulin re-
sistance is not completely understood; however, it is believed
to involve the impairment of the insulin receptor (IR) sig-
naling network. The cascade begins when activation of the IR
by autophosphorylation on several tyrosine residues leads to
the recruitment and tyrosine phosphorylation of IR substrate
(IRS) proteins (3, 4). Then, phosphorylated IRSs bind proteins
containing Src homology 2 domains such as phosphatidyl-
inositol (PI) 3-kinase (5), which has a central role in the
metabolic actions elicited by insulin. Over the last years, the
role of insulin signaling pathways in the liver has also been
studied in mice lacking hepatic IR (6), IRS-2 (7–12), phos-
phoinositide-dependent protein kinase-1 (13), protein kinase
B  (PKB/Akt ) (14), and also in mice overexpressing a
dominant negative mutant of PI 3-kinase (15). Various lines
of genetic evidence support the concept that insulin nega-
tively regulates hepatic glucose production through a main
pathway involving IR, IRS-2, PI 3-kinase, and Akt .
Given the importance of insulin signaling in multiple bi-
ologic responses, activation of this pathway must be tightly
regulated. Protein tyrosine phosphatases (PTPs) catalyze the
dephosphorylation of tyrosyl-phosphorylated proteins (16)
and are known to be important negative regulators of IR
signaling (17). Protein tyrosine phosphatase 1B (PTP1B) di-
rectly interacts with the activated IR (18, 19) and exhibits high
specific activity for IRS-1 (20). It has been reported that over-
expression of PTP1B in hepatic cellular models such as Fao
hepatoma cells impairs insulin-stimulated glucose metabo-
lism (21). Conversely, reduction of PTP1B in these cells in-
creased insulin signaling (22). Furthermore, in vivo experi-
ments have demonstrated that reduction of PTP1B
expression by 60% in the liver of ob/ob mice increased IRS-
1/2 tyrosine phosphorylation and Akt activation in response
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to insulin (23). Mice lacking the ptpn1 gene (PTP1B/) ex-
hibited increased insulin sensitivity at 10–14 wk of age owing
to enhanced phosphorylation of IR in liver and skeletal mus-
cle, resistance to weight gain on a high-fat diet, and an in-
creased basal metabolic rate (24, 25). However, the molecular
mechanism by which the increased insulin sensitivity is ac-
quired during postnatal development of PTP1B-deficient
mice has not been investigated. In fact, there are few pub-
lished reports related to the developmental aspects of glu-
cose tolerance and insulin sensitivity. To address this im-
portant issue, we have generated immortalized neonatal
hepatocyte cell lines from wild-type and PTP1B/ mice.
These cell lines are novel and unique tools designed to elu-
cidate the molecular mechanism of PTP1B-mediated insulin
action in the neonatal liver given that their expression of
hepatocyte markers and insulin signaling molecules is sim-
ilar to liver extracts from wild-type and PTP1B-deficient
neonates. In this article, we demonstrate that, in contrast to
adult PTP1B knockout mice that show increased hepatic
insulin sensitivity after in vivo insulin administration (24, 26),
the lack of PTP1B in neonatal hepatocytes causes a significant
prolongation of insulin signaling through PI 3-kinase/Akt
without altering insulin sensitivity. As a result, prolonged
inhibition of gluconeogenic gene expression occurred in
these cells. Interestingly, our studies reveal that hepatic in-
sulin sensitivity due to PTP1B deficiency is acquired during
postnatal development, paralleling changes to the expression
of IR and IRS-2 and the establishment of a molecular balance
between the regulatory and the catalytic subunits of PI 3-ki-
nase. These molecular alterations are absolutely required to
achieve an insulin-sensitizing effect in adult hepatocytes
lacking PTP1B.
Materials and Methods
Materials
Fetal serum (FS) and culture media were obtained from Invitrogen
(Gaithersburg, MD). Insulin and antimouse IgG-agarose were from
Sigma Chemical Co. (St. Louis, MO). IGF-I was from Calbiochem (Cal-
biochem-Novabiochem International, La Jolla, CA). Protein A-agarose
was from Roche Molecular Biochemicals (Mannheim, Germany). (32P)-
ATP (3000 Ci/mmol), (32P)-dCTP (3000 Ci/mmol), and the cDNA
labeling kit were from Amersham (Aylesbury, UK).
Culture of neonatal hepatocytes and retroviral infections
PTP1B-deficient mice (25) were obtained from Abbott Laboratories
(Abbott Park, IL). All animal experimentation described in this article
was conducted in accord with accepted standards of human animal care.
Four pools of four to six livers from wild-type (PTP1B/) and
PTP1B/ neonates (3.5–5 d old) were submitted to collagenase dis-
persion for the preparation of primary cultures as previously described
(27). Viral Bosc-23 packaging cells were transfected at 70% confluence
with a 3 g/6-cm dish of the puromycin-resistance retroviral vector
pBabe encoding Simian virus 40 large T antigen (LTAg) (kindly pro-
vided by J. de Caprio, Dana Farber Cancer Institute, Boston, MA) as
previously described (11). Then, neonatal hepatocytes were infected at
60% confluence with polybrene (4 g/ml)-supplemented virus for 48 h,
maintained in culture medium for 72 h, and selected with puromycin
(0.5–1 g/ml) for 1 wk. Pools of infected cells rather than individual
clones were selected to avoid potential clone-to-clone variations. Im-
mortalized cell lines were further cultured for at least 2 wk with arginine-
free medium supplemented with 10% FS and ornithine to avoid growth
of nonparenchymal cells. Experiments were performed using three in-
dependent cell lines from each genotype, which were obtained by im-
mortalization of distinct preparations of neonatal hepatocytes.
PTP1B/ neonatal hepatocytes were reconstituted with retroviral
Myc-tagged PTP1B (kindly provided by M. L. Tremblay, McGill Cancer
Center, Quebec, Canada) and four pools of infected cells were selected
with hygromycin B (200 g/ml) for 2 wk. As a control, PTP1B-deficient
hepatocytes were infected with an empty vector (pBabe hygro). The
expression of PTP1B in the different cell lines was assessed by Western
blot.
Primary culture of adult hepatocytes
Hepatocytes were isolated from nonfasting male wild-type and
PTP1B-deficient mice (10–12 wk old) by perfusion with collagenase as
described (28). Cells were plated on 60-mm primaria dishes (Falcon; BD
Biosciences, San Jose, CA) and cultured in William’s E medium sup-
plemented with 20 ng/ml epidermal growth factor, 100 U/ml penicillin,
100 g/ml streptomycin, and 10% FS for 48 h. Then, cells were deprived
of serum and used for experiments.
Immunofluorescence and confocal imaging
Immortalized neonatal hepatocytes were grown in glass coverslips
until 80% confluence was reached. Then, cells were washed twice with
PBS, fixed in methanol (20 C) for 2 min, and processed to immuno-
fluorescence. Monoclonal anti-vimentin (VIM) (cloneV9) antibody was
from Roche Molecular Biochemicals, polyclonal anti-albumin (ALB) an-
tibody was from Nordic Immunology Laboratories (Tilbury, The Neth-
erlands), and monoclonal anti-carbamoyl phosphate synthetase (CPS)
antibody was a gift of Dr. P. Martı´n-Sanz (Consejo Superior de Inves-
tigaciones Cientificas, Madrid, Spain). Primary antibodies were applied
for 1 h at 37 C in PBS 1% BSA followed by four 5-min washes in PBS,
a 45-min incubation with fluorescence-conjugated secondary antibodies
[fluorescein isothiocyanate (FITC)-conjugated sheep antimouse and
Cy3-conjugated goat antirabbit], and four final washes of 5 min each in
PBS. Immunofluorescence was examined in an MRC-1024 (Bio-Rad,
Hemel Hempstead, UK) confocal microscope adapted to an inverted
Nikon Eclipse TE 300 microscope. Immunofluorescence mounting me-
dium was from Vector Laboratories (Burlingame, CA). Images were
taken with 488-nm laser excitation for FITC-conjugated antibodies and
514-nm laser excitation for Cy3-conjugated antibodies. Fluorescence
emissions were detected through a 513/24-nm bandpass filter for FITC
and a 605/15-nm bandpass filter for Cy3.
Transient transfection with small interfering RNA (siRNA)
siRNA oligos were synthesized by Ambion Inc. (Austin, TX). PTP1B
siRNA oligo1 corresponded to nucleotides 209–229 of the mouse se-
quence, and PTP1B siRNA oligo2 was previously described (29). Wild-
type immortalized hepatocytes were seeded in 10-cm dishes for 2–3 d
before transfection (60–70% confluence). Cells were trypsinized and
electrophoresed with the indicated specific siRNA oligonucleotides (1.5
g) by using Amaxa Nucleofector technology (Amaxa GmbH, Cologne,
Germany) following the manufacturer’s instructions. Cells were re-
plated in six-well plates and maintained in growing medium (10%
FS-DMEM) for a further 48 h. Then, hepatocytes were serum starved for
15 h and stimulated with 10 nm insulin for several time periods.
Homogenization and preparation of tissue extracts
Frozen livers were homogenized in 16 vol (weight/volume) of ice-
cold lysis buffer containing 50 mm Tris-HCl, 1% Triton X-100, 2 mm
EGTA, 10 mm EDTA, 100 mm NaF, 1 mm Na4P2O7, 2 mm Na3VO4, 100
g/ml phenylmethylsulfonyl fluoride, 1g/ml aprotinin, 1g/ml pep-
statin A, and 1 g/ml leupeptin. Liver was homogenized in the same
lysis buffer using the Brinkmann PT 10/35 Polytron. Extracts were kept
ice cold at all times. Liver extracts were cleared by microcentrifugation
at 15,000 g for 20 min at 4 C. The supernatant was aliquoted and stored
at 70 C.
Immunoprecipitations and Western blot
Quiescent cells (15 h serum starved) were treated without or with
several doses of insulin or IGF-I for several times and lysed as previously
described (30). After protein content determination, equal amounts of
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protein (600 g–1 mg) were immunoprecipitated at 4 C with the cor-
responding antibodies. The immune complexes were collected on aga-
rose beads and submitted for Western blot analysis. The anti-IRS-1
(06-248), anti-phosphotyrosine [Tyr(P)] (clone 4G10, 05-321), and anti-
IRS-2 (06-506) antibodies were purchased from Upstate Biotechnology
(Lake Placid, NY). The anti-phospho Akt (Ser473 no. 9271), anti-phospho
p70S6 kinase 1 (S6K1) (Ser424/Thr421 no. 9204), anti-Akt (no. 9272),
anti-phospho glycogen synthase kinase (GSK) 3 / (Ser 21/9 no. 9331),
and anti-phospho Foxo1 (Ser256 no. 9461) antibodies were purchased
from Cell Signaling Technology (Beverly, MA). The anti-IR -chain
antibody used for immunoprecipitations was from Oncogene (Cam-
bridge, MA) (Ab-3, GR07) and for Western blot (C-19, sc-711) was from
Santa Cruz Biotechnology (Palo Alto, CA). The anti--actin antibody
was from Sigma. Immunoreactive bands were visualized using en-
hanced chemiluminescence (Amersham).
PI 3-kinase activity
PI 3-kinase activity was measured in the immunoprecipitates by in
vitro phosphorylation of PI as previously described (30).
Protein determination
Protein determination was performed by the Bradford dye method
(Bio-Rad).
RNA extraction from primary hepatocytes and Northern
blot analysis
Primary hepatocytes were isolated from livers of 3.5- to 5-d-old ne-
onates or 10- to 12-wk-old mice and cultured as described (27, 28). Then,
cells were serum starved for 12–15 h and further incubated for 6 h in the
presence of 0.5 mm dibutyryl cAMP plus 1 m dexamethasone (dex/
cAMP) either in the absence or in the presence of insulin (0.1–100 nm)
for several time periods. At the end of the culture time, total RNA was
isolated with Trizol (Invitrogen) and 20 g were submitted to Northern
blot analysis. Blots were hybridized with cDNA probes for phos-
phoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase
(G6Pase). Membranes were subjected to autoradiography and the rel-
ative densities of the hybridization signals were determined by densi-
tometric scanning of the autoradiograms.
Statistical analysis
All values are presented as mean se. Comparisons between groups
were made using unpaired two-tailed Student’s t test. Differences were
considered statistically significant at P  0.05.
Results
Generation and characterization of immortalized hepatocyte
cell lines from PTP1B/ and PTP1B/ neonates
Immortalized neonatal hepatocyte cell lines were gener-
ated from four pools of four to six livers of either wild-type
(PTP1B/) or PTP1B/ mice at postnatal d 3.5–5. It is
important to note that immortalized neonatal hepatocytes
were further cultured for 10–15 d in arginine-free medium
(supplemented with ornithine) to select hepatocytes having
functional urea cycle. As shown in Fig. 1A, all PTP1B/
immortalized neonatal hepatocytes expressed similar levels
of PTP1B; as expected, no expression of this phosphatase was
detected in immortalized PTP1B/ neonatal hepatocytes. In
addition, levels of LTAg were similar in all cell lines on
immortalization as assessed by Western blot.
Wild-type and PTP1B/ neonatal hepatocytes expressed
ALB (a plasma protein secreted exclusively by hepatocytes)
together with CPS (a urea cycle marker), indicating that on
immortalization, these cells maintained hepatocyte pheno-
typic features (Fig. 1B). As a negative control, we performed
immunofluorescence experiments with immortalized -cells
previously generated in our laboratory (31). Immunofluo-
rescence was not detected in these immortalized -cells,
thereby confirming the specificity of ALB and CPS antibod-
ies. Moreover, the absence of VIM (a cytoskeletal marker
characteristic of fibroblasts) staining demonstrated that the
maintenance of cell lines in arginine-free medium was suf-
ficient to eliminate contaminating fibroblasts in the primary
culture.
Next, we determined whether the lack of PTP1B in im-
mortalized neonatal hepatocytes modifies the endogenous
expression of various proteins of the insulin signaling cas-
cade. As depicted in Fig. 1C, a significant reduction in the
expression of IR -chain was observed in immortalized
PTP1B/ hepatocytes compared with wild-type controls.
Interestingly, IRS-2 expression was also down-regulated but,
in contrast, IRS-1 protein content was up-regulated in im-
mortalized PTP1B/ neonatal hepatocytes compared with
the wild type. Importantly, the net increase in IRS-1 and the
net decrease in IR and IRS-2 expression were similar in
PTP1B-deficient immortalized neonatal hepatocytes, pri-
mary neonatal hepatocytes, and liver extracts, strongly sug-
gesting that the absence of PTP1B rather than the immor-
talization process mediates the observed alterations in
protein expression. No differences in the levels of p85, Akt,
and S6K1 were noted between immortalized PTP1B/ and
PTP1B/ neonatal hepatocytes and liver extracts (Fig. 1C).
Thus, this novel cellular model is physiologically relevant
and has allowed us to analyze the molecular mechanism of
PTP1B deficiency in insulin signaling in neonatal
hepatocytes.
Lack of insulin sensitivity in PTP1B-deficient
neonatal hepatocytes
To determine whether PTP1B deficiency improves insulin
sensitivity in immortalized neonatal hepatocytes, quiescent
PTP1B/ and PTP1B/ cells were stimulated for 5 min
with various doses of insulin and IR -chain tyrosine phos-
phorylation was analyzed. Maximal IR -chain tyrosine
phosphorylation was elicited at 10 nm concentration in both
cell types (Fig. 2A). Unexpectedly, IR tyrosine phosphory-
lation was higher in wild-type cells. However, after normal-
ization with the total amount of IR -chain immunoprecipi-
tated in each condition, no differences were found. In
addition, insulin-induced anti-Tyr(P)-associated PI 3-kinase
activity was unaffected by the lack of PTP1B (Fig. 2A). Next,
we investigated whether the lack of PTP1B in immortalized
neonatal hepatocytes increased insulin sensitivity with re-
spect to Akt phosphorylation. This experiment was per-
formed because it has been reported that Akt associates with
and is dephosphorylated by protein phosphatase 2A (PP2A)
(32) and negatively regulates insulin’s metabolic signaling
pathways (33). More importantly, overexpression of PTP1B
decreases tyrosine phosphorylation and, consequently, in-
creases PP2A activity in rat hepatocytes (34). Therefore, we
stimulated wild-type and PTP1B/ hepatocytes with var-
ious doses of insulin for 5 min and analyzed Akt phosphor-
ylation by direct Western blot. As shown in Fig. 2A, phos-
phorylation of Akt was maximal at 10 nm insulin
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concentration in both cell types. However, PTP1B/ hepa-
tocytes displayed significant Akt phosphorylation in the
basal state and after stimulation with lower doses of insulin
(0.1–1 nm) compared with the wild-type controls. To further
explore this effect, we performed anti-PP2A Western blot
analysis of anti-Tyr(P) immunoprecipitates. In wild-type
cells, phosphorylation of both PP2A tyrosine and Akt serine
473 was low in the absence of insulin. After stimulation,
PP2A and Akt phosphorylation increased in a dose-depen-
dent manner. By contrast, in PTP1B-deficient hepatocytes,
both proteins were highly phosphorylated in the absence of
insulin. After treatment with low doses of insulin (0.1–1 nm),
phosphorylation of PP2A and Akt was greater than in wild-
type controls. However, at higher insulin concentrations (10–
100 nm), no differences were observed between both cell
types. Given that no significant differences in either IR
-chain tyrosine phosphorylation or anti-Tyr(P)-associated
PI 3-kinase activity were noted between wild-type and
PTP1B/ neonatal hepatocytes, these results suggest that
possible downstream mechanisms such as inactivation of
PP2A in a PTP1B-dependent manner might modulate Akt
phosphorylation.
There are recent observations in vivo in adult mice sug-
gesting that the liver is a major site of the peripheral action
of PTP1B in regulating glucose homeostasis (26). Accord-
ingly, our next step was to study in vitro whether the lack of
PTP1B in neonatal hepatocytes modifies the negative regu-
lation of gluconeogenic gene expression by insulin. Toward
this end, we prepared primary hepatocytes from PTP1B/
and PTP1B/ neonates (3.5–5 d old). The reason for using
primary cells to conduct these experiments is the fact that, in
immortalized neonatal hepatocytes, PEPCK and G6Pase
were only modestly increased after dexamethasone plus
dibutyryl cAMP (dex/cAMP) treatment. As shown in Fig.
2B, both PEPCK and G6Pase mRNAs were highly induced by
dex/cAMP in primary neonatal hepatocytes regardless of
PTP1B expression. These experimental conditions allowed
us to study the effect of insulin on both genes. Insulin treat-
FIG. 1. Characterization of immortalized neonatal hepatocyte cell lines. A, Immortalized neonatal hepatocytes from wild-type and PTP1B-
deficient newborn mice (3.5–5 d old) were generated as described in Materials and Methods. Growing cells were lysed and PTP1B and LTAg
expression of four independent cell lines fromeach genotypewas analyzed inwhole-cell lysates byWestern blot. B, Immunofluorescence detection
of ALB, CPS, and VIM of growing immortalized neonatal hepatocytes (PTP1B/ and PTP1B/). As a negative control for ALB and CPS
antibodies, immortalized -cells were used for immunofluorescence. As a positive control for VIM, mouse embryo fibroblasts were used.
Representative images are shown. C, Cell lysates from immortalized neonatal hepatocytes, primary neonatal hepatocytes, or livers from six
to eight PTP1B/ and PTP1B/ neonates were analyzed by Western blot with antibodies against IR, IRS-1, IRS-2, p85, S61, and Akt. A
representative experiment is shown. The autoradiograms showing IR, IRS-1, and IRS-2 expression in three different cell lines of immortalized
neonatal hepatocytes, primary neonatal hepatocytes, and neonatal livers from each genotype were quantitated by scanning densitometry.
Results are expressed as percentage of increase of IRS-1 expression or percentage of decrease of IR and IRS-2 expression of primary and
immortalized PTP1B/ hepatocytes and PTP1B/ liver extracts compared with the wild type (set to 100%) and are means  SE. Statistical
significance was carried out by Student’s t test. *, P  0.05 was considered significant.
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ment inhibited dex/cAMP-induced PEPCK and G6Pase mR-
NAs in a dose-dependent manner with total inhibition being
observed at 10 nm in both cell types.
Prolonged IR tyrosine phosphorylation in immortalized
PTP1B-deficient neonatal hepatocytes
Because no differences in insulin sensitivity were found
between immortalized wild-type and PTP1B-deficient hepa-
tocytes from neonates, we explored the possibility of a dif-
ferential time course of insulin signaling. Thus, we per-
formed a detailed time course of IR -chain tyrosine
phosphorylation in both cell types. Quiescent cells were se-
rum starved for 15 h and subsequently stimulated with 10 nm
insulin for 1 min–15 h. Then, tyrosine phosphorylation of IR
-chain was analyzed in anti-IR immunoprecipitates. As
shown in Fig. 3A, insulin strongly induced tyrosine phos-
phorylation of IR -chain in immortalized wild-type neona-
tal hepatocytes, reaching a maximal effect at 1 min. This
response was sustained for 5 min but declined at 15 min, with
no tyrosine phosphorylation being observed after 1 h of
insulin treatment. Although IR -chain protein content is
reduced in PTP1B/ neonatal hepatocytes (Figs. 1C and
2A), insulin-mediated tyrosine phosphorylation of the IR
was quite different in these cells; maximal phosphorylation
was sustained from 1 min up to 2 h of insulin stimulation.
It is well known that IGF-I receptors (IGF-IR) can mediate
actions of insulin at high concentrations. To exclude the
possibility that 10 nm insulin triggers the phosphorylation of
IGF-IR in neonatal hepatocytes, immortalized wild-type and
PTP1B/ hepatocytes were stimulated with 10 nm insulin
for 5 min, and IGF-IR tyrosine phosphorylation was ana-
lyzed in anti-IGF-IR immunoprecipitates. As a control, im-
mortalized -cells were stimulated with 10 nm IGF-I. As
depicted in Fig. 3B, insulin at 10 nm concentration did not
induce IGF-IR tyrosine phosphorylation in either wild-type
or PTP1B-deficient hepatocytes. Of note, IGF-IR expression
was comparable in both kinds of cells.
Prolonged IRS-1, -2/PI 3-kinase signaling in immortalized
neonatal hepatocytes lacking PTP1B
Our next aim was to study whether the prolonged insulin-
induced IR tyrosine phosphorylation provoked by PTP1B
FIG. 2. Dose-response effects on insulin signaling and gluconeogenic gene expression in wild-type and PTP1B-deficient neonatal hepatocytes.
A (left panel), Quiescent immortalized wild-type (PTP1B/) and PTP1B-deficient (PTP1B/) neonatal hepatocytes were stimulated with
insulin (0.1–100 nM) for 5 min. Control cells were cultured in the absence of the hormone. At the end of the culture time, cells were lysed and
1 mg of total protein was immunoprecipitated with the anti-IR -chain antibody. The resulting immune complexes were analyzed by Western
blotting with the anti-Tyr(P) antibody or the anti-IR -chain antibody. Akt phosphorylation was measured by direct Western blot analysis with
the anti-phosphoAkt antibody. Tyrosine phosphorylation of PP2Awasmeasured by immunoprecipitating 600g of total proteinwith anti-Tyr(P)
antibody followed by Western blot with anti-PP2A antibody. The experiment was repeated twice with similar results. Right panel, Cells were
stimulated as described previously. At the end of the culture time, cells were lysed and 600 g of total protein, immunoprecipitated with the
anti-Tyr(P) antibody, was immediately used for an in vitro PI 3-kinase assay. The conversion of PI to PIP in the presence of (32-P) ATP was
analyzed by thin layer chromatography (TLC). The autoradiograms corresponding to three independent experiments, performed in three
different cell lines from each genotype, were quantitated by scanning densitometry. The value of nonstimulated PTP1B/ and PTP1B/ cells
was set to 1. Results are expressed as fold increase by insulin of Tyr(P)-associated PI 3-kinase activity and are means SE. B, Primary neonatal
hepatocytes, obtained from pools of 3.5- to 5-d-old mice, were cultured to confluence. Cells were serum starved for 12–15 h and further cultured
for 6 h without or with 0.5 mM dibutyril cAMP plus 1 M dexamethasone (dex/cAMP). Then, various doses of insulin were added for a further
6 h. At the end of the culture time, total RNAwas isolated, submitted to Northern blot analysis, and hybridized with labeled PEPCK andG6Pase
cDNAs. Representative autoradiograms are shown. The autoradiograms corresponding to four independent experiments were quantitated by
scanning densitometry. The value of dex/cAMP-treated cells was set to 100%. Results are expressed as percentage of decrease by insulin of
PEPCK and G6Pase mRNAs of primary PTP1B/ neonatal hepatocytes compared with the wild type and are means  SE.
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deficiency in immortalized neonatal hepatocytes is trans-
duced through IRS-1 and/or IRS-2/PI 3-kinase pathway,
which in fact mediates most of the metabolic actions of in-
sulin in the liver. Tyrosine phosphorylation of IRS-1, as well
as its association with p85 and activation of IRS-1-associ-
ated PI 3-kinase activity, decreased after 15–30 min of insulin
stimulation in PTP1B/ neonatal hepatocytes (Fig. 4, upper
panel). In sharp contrast, the effect of insulin on IRS-1 tyrosine
phosphorylation in PTP1B/ neonatal hepatocytes was
prolonged; tyrosine phosphorylation of IRS-1, IRS-1/p85
association, and IRS-1-associated PI 3-kinase activity was
sustained for 4 h in PTP1B/ neonatal hepatocytes (Fig. 4,
lower panel). Similar to findings for IRS-1, IRS-2 tyrosine phos-
phorylation, its binding to p85, and activation of IRS-2-
associated PI 3-kinase activity decreased between 15 and 60
min in insulin-stimulated PTP1B/ neonatal hepatocytes
(Fig. 5, upper panel). However, insulin action was prolonged
up to 4 h on this signaling pathway in PTP1B/ neonatal
hepatocytes (Fig. 5, lower panel). Taken all together, our re-
sults suggest that both IRS-1 and IRS-2 signaling contribute
to the prolonged PI 3-kinase activation in immortalized neo-
natal hepatocytes in the absence of PTP1B.
Sustained insulin signaling downstream of PI 3-kinase in
immortalized neonatal hepatocytes lacking PTP1B
Downstream of PI 3-kinase, various serine/threonine ki-
nases become activated after insulin stimulation. As shown
in Fig. 6, insulin stimulated Akt phosphorylation up to 30
min in immortalized wild-type neonatal hepatocytes. This
effect was markedly prolonged (up to 4 h) in PTP1B/ cells.
It is noteworthy that, in PTP1B/ neonatal hepatocytes,
there is a significant basal phosphorylation of Akt compared
with wild-type control cells. Downstream of Akt, both GSK3
( and  isoforms) and Foxo 1 were phosphorylated after
short-term insulin stimulation in wild-type cells. However,
in PTP1B/ neonatal hepatocytes, GSK3 (mainly GSK3
isoform) and Foxo1 displayed prolonged phosphorylation in
response to insulin stimulation. In addition, S6K1, a mam-
malian target of rapamycin target, showed a similar profile
of short-term (wild-type) and long-term (PTP1B/) phos-
phorylation in response to insulin. Thus, the lack of PTP1B
prolonged insulin activation of the PI 3-kinase/Akt signaling
pathway, which might have physiological consequences in
neonatal hepatocytes.
Effect of PTP1B reconstitution or siRNA-mediated
suppression of PTP1B on insulin signaling in immortalized
neonatal hepatocytes
To test that the lack of PTP1B is indeed responsible for
prolonged insulin signaling in immortalized PTP1B-defi-
cient neonatal hepatocytes, we reconstituted PTP1B expres-
sion by retroviral gene transfer. As a control, PTP1B/
neonatal hepatocytes were infected with an empty retroviral
construct. Figure 7A reveals the levels of ectopic expression
of PTP1B in four different pools of PTP1B/ immortalized
neonatal hepatocytes (PTP1B/Rec). Expression of recom-
binant PTP1B in deficient neonatal hepatocytes restored a
decline of IR -chain tyrosine phosphorylation after 30 min
of insulin stimulation, similar to the effects of insulin in
wild-type cells (Figs. 3A and 7B). In addition, the time course
FIG. 3. Time course of IR -chain tyrosine phosphorylation in insulin-stimulated immortalized wild-type and PTP1B-deficient neonatal
hepatocytes. A, Quiescent immortalized neonatal hepatocytes (PTP1B/ and PTP1B/) were stimulated with 10 nM insulin for 1 min to 15 h.
At the end of the culture time, cells were lysed and 1 mg of total protein was immunoprecipitated with anti-IR -chain antibody. The resulting
immune complexes were analyzed by Western blotting with anti-Tyr(P) or anti-IR antibodies as indicated in each panel. A representative
experiment is shown. The autoradiograms corresponding to three independent experiments, performed in three different cell lines from each
genotype, were quantitated by scanning densitometry. The value of nonstimulated PTP1B/ and PTP1B/ cells was set to 1. Results are
expressed as fold increase by insulin of tyrosine phosphorylation of IR and are means SE. Statistical significance was carried out by Student’s
t test comparing immortalized PTP1B/ neonatal hepatocytes with the respective values of wild-type cells. *, P  0.05 was considered
significant. B, Quiescent immortalized neonatal hepatocytes (PTP1B/ and PTP1B/) were stimulated with 1–10 nM insulin for 5 min. As
a control, immortalized -cells were treated with 10 nM IGF-I for 5 min. At the end of the culture time, cells were lysed and 600 g of total
protein was immunoprecipitated with anti-IGF-IR antibody. The resulting immune complexes were analyzed by Western blotting with
anti-Tyr(P) or anti-IGF-IR antibodies as indicated in each panel. The results shown are representative of three experiments performed in three
independent cell lines from each genotype.
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of insulin-mediated Akt phosphorylation in PTP1B/Rec
neonatal hepatocytes was comparable to that observed in
wild-type cells (Figs. 6 and 7B).
To further demonstrate that PTP1B regulates PI 3-kinase/
Akt insulin signaling in neonatal hepatocytes, we established
RNA interference (siRNA) assays in wild-type cells. As de-
picted in Fig. 8, reduction of PTP1B expression by 70% in
wild-type cells with two different siRNA oligos prolonged
the effects of insulin on IR -chain tyrosine phosphorylation
as well as on phosphorylation of Akt, Foxo1, GSK3, and
S6K1. Thus, both experimental approaches (rescue of PTP1B
and siRNA) reinforce our findings in immortalized PTP1B-
deficient neonatal hepatocytes.
PTP1B deficiency prolongs inhibition of gluconeogenic gene
expression by insulin in neonatal hepatocytes
The fact that the disruption of the ptpn1 gene did not
increase insulin sensitivity in neonatal hepatocytes
prompted us to study in vitro whether the prolonged insulin
signaling via PI 3-kinase/Akt in PTP1B/ neonatal hepa-
tocytes could modulate the timing of the suppression of
gluconeogenic gene expression by insulin. As depicted in
Fig. 9A, insulin inhibited gluconeogenic gene expression in
a time-dependent manner in neonatal hepatocytes, with total
inhibition of PEPCK and G6Pase mRNAs being observed
after 90 min of insulin treatment, independently of PTP1B
expression. However, when we analyzed the long-term in-
hibitory effect of insulin on dex/cAMP-induced PEPCK and
G6Pase mRNAs, substantial differences were found.
Whereas insulin was able to suppress gluconeogenic gene
expression for 12 h in wild-type neonatal hepatocytes, this
effect was prolonged up to 36 h in PTP1B-deficient cells (Fig.
9B).
Expression profile of key molecules of the insulin signaling
cascade in the liver from adult PTP1B-deficient mice
We assessed the possibility that the striking differences in
insulin signaling between neonatal PTP1B-deficient hepato-
cytes (this paper) and the adult liver (26) could be due to a
different pattern of endogenous protein expression of the key
molecules of insulin signaling network through postnatal
development. For this goal, protein extracts were obtained
from four to six livers of adult mice (10–12 wk old) from both
genotypes. Then, the expression of the key molecules of the
insulin signaling was analyzed. Substantial differences were
found in the liver between adult (Fig. 10A) and neonatal (Fig.
1C) PTP1B-deficient mice regarding protein expression.
Whereas the expression of IR -chain was down-regulated in
neonatal PTP1B-deficient liver as compared with the neo-
natal wild type, no differences between both genotypes were
observed in adult liver. Moreover, IRS-1 and IRS-2 protein
content was similar in livers from wild-type and PTP1B/
adult mice. Conversely, the expression of the p85 regulatory
subunit of PI 3-kinase was significantly down-regulated
(55%) in adult (Fig. 10A) but not in neonatal (Fig. 1C)
PTP1B-deficient liver as compared with the corresponding
wild-type controls. Collectively, these results show that, in
PTP1B-deficient mice, the hepatic expression profile of key
FIG. 4. Insulin effect on IRS-1-tyrosine phosphorylation and IRS-1-associated PI 3-kinase activity in immortalized wild-type and PTP1B-
deficient neonatal hepatocytes. Quiescent immortalized neonatal hepatocytes (PTP1B/ and PTP1B/) were stimulated with 10 nM insulin
for 1 min to 15 h or cultured in the absence of the hormone. At the end of the culture time, cells were lysed and 600 g of total protein,
immunoprecipitated with anti-IRS-1 antibody, was analyzed by Western blot with anti-Tyr(P), anti-p85, and anti-IRS-1 antibodies or used
for an in vitro PI 3-kinase assay. The conversion of PI to PIP in the presence of [32-P] ATP was analyzed by TLC. A representative experiment
is shown. The autoradiograms corresponding to three independent experiments, performed in three different cell lines from each genotype, were
quantitated by scanning densitometry. The value of nonstimulated PTP1B/ and PTP1B/ cells was set to 1. Results are expressed as fold
increase by insulin of tyrosine phosphorylation of IRS-1 or IRS-1-associated PI 3-kinase activity and are means  SE. Statistical significance
was carried out by Student’s t test comparing immortalized PTP1B/ neonatal hepatocytes with the respective values of wild-type cells. *, P
0.05 was considered significant.
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mediators of insulin signaling switches in the neonatal/adult
transition.
Increased insulin sensitivity in primary hepatocytes from
adult PTP1B-deficient mice
Next, we investigated whether the expression profile of
insulin signaling molecules in adult PTP1B-deficient liver
can account for an increase in insulin sensitivity in hepato-
cytes. Thus, we prepared primary hepatocytes from adult
wild-type and PTP1B/ mice to analyze insulin signaling.
Cells were serum deprived for 6–8 h and then several doses
of insulin were added for 10 min. As shown in Fig. 10B,
phosphorylation of Akt was barely detected after stimulation
with 1 nm insulin in adult hepatocytes from wild-type mice.
By contrast, at the same dose, maximal phosphorylation of
Akt was elicited in PTP1B/ adult hepatocytes. A similar
trend was noted with respect to the phosphorylation of
Foxo-1 and GSK-3.
Finally, we analyzed the ability of insulin to suppress
PEPCK and G6Pase mRNAs in adult hepatocytes lacking
PTP1B. Primary hepatocytes were incubated with dex/
cAMP before treatment with 10 nm insulin for 6 h. Then, the
expression of PEPCK and G6Pase was analyzed by Northern
blot. As shown in Fig. 10C, addition of insulin completely
blocked the induction of PEPCK and G6Pase mRNAs by
dex/cAMP in PTP1B/ adult hepatocytes. However, a rem-
nant of 25% and 50% of G6Pase and PEPCK mRNAs, re-
spectively, was detected in insulin-treated wild-type cells.
Discussion
The control of insulin signaling is complex, involving the
coordinated action of both positive and negative regulatory
proteins. Of these, PTP1B is a major negative regulatory
protein as demonstrated by the positive effects of deleting the
ptpn1 gene on insulin sensitivity, energy expenditure, and
lipoprotein secretion (24, 25, 35). Thus, although it is clear
that PTP1B plays a role in insulin sensitivity and glucose
homeostasis, the molecular mechanism of how this protein
may play a tissue-specific role is not completely understood.
Nevertheless, the suppression of PTP1B has been proposed
as beneficial treatment for type 2 diabetes, and various phar-
macological PTP1B inhibitors are under development (36).
The specific role of PTP1B in insulin action in the liver has
been a controversial issue. Wang et al. (37) reported that
adenovirus-mediated liver-specific overexpression of PTP1B
in rats did not alter insulin action. Conversely, it has been
recently shown that liver-specific PTP1B rescue in PTP1B-
deficient mice led to attenuation of enhanced insulin sensi-
tivity, strongly suggesting that the liver is a major site of
PTP1B action in the periphery (26). Moreover, PTP1B defi-
FIG. 5. Insulin effect on IRS-2-tyrosine phosphorylation and IRS-2-associated PI 3-kinase activity in immortalized wild-type and PTP1B-
deficient neonatal hepatocytes. Quiescent cells were stimulated with 10 nM insulin for 1 min to 15 h or cultured in the absence of the hormone.
At the end of the culture time, cells were lysed and 600 g of total protein, immunoprecipitated with anti-IRS-2 antibody, was analyzed by
Western blot with anti-Tyr(P), anti-p85, and anti-IRS-2 antibodies or used for an in vitro PI 3-kinase assay. The conversion of PI to PIP in
the presence of [32-P]ATP was analyzed by TLC. A representative experiment is shown. The autoradiograms corresponding to three inde-
pendent experiments were quantitated by scanning densitometry. The value of nonstimulated PTP1B/ and PTP1B/ cells was set to 1.
Results are expressed as fold increase by insulin of tyrosine phosphorylation of IRS-2 or IRS-2-associated PI 3-kinase activity and are means
SE. Statistical significancewas carried out by Student’s t test comparing immortalizedPTP1B/neonatal hepatocyteswith the respective values
of wild-type cells. *, P  0.05 was considered significant.
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ciency delays onset of type 2 diabetes in IRS-2-deficient mice
(38). The fact that immortalized neonatal hepatocytes devel-
oped in our laboratory have provided a unique tool for the
in vitro study of insulin signaling leading to the expression
of genes implicated in liver glucose metabolism (11) and
survival (12) prompted us to generate immortalized hepa-
tocytes from wild-type and PTP1B-deficient neonates. By
using this model system, we have addressed whether the
increase in insulin sensitivity provoked by PTP1B deficiency
in adult liver is acquired through postnatal development.
PTP1B/ and PTP1B/ immortalized neonatal hepato-
cyte cell lines were grown in arginine-free medium to select
cells with functional urea cycle. Consequently, we have cir-
cumvented the potential contamination of the primary cul-
tures with nonparenchymal cells as confirmed by the absence
of anti-VIM staining. In addition, all cell lines maintained the
expression of hepatocyte markers such as ALB and CPS.
Unexpectedly, our studies reveal that, in contrast to very
recent data published in livers from adult mice (26), PTP1B-
deficient neonatal hepatocytes did not display increased sen-
sitivity to insulin in the early steps of the insulin signaling
network. In particular, tyrosine phosphorylation of IR
-chain and IRS-1, -2-associated PI 3-kinase activity was un-
affected by the lack of PTP1B at a wide range of insulin
concentrations (0.1–100 nm). However, we have observed
significant differences in the expression of these endogenous
proteins between immortalized PTP1B/ and PTP1B/
neonatal hepatocytes. Surprisingly, the expression of IR
-chain was down-regulated in immortalized PTP1B/
neonatal hepatocytes without an accompanying change in
the expression of the IGF-IR. This phenomenon might be
regulated by tissue-specific developmental mechanisms be-
cause this pattern of IR expression was not observed in
PTP1B-deficient fibroblasts (39). Alternatively, these results
can be explained on the basis of recent data (40) demon-
strating basal (insulin-independent) interaction of PTP1B
with IR during biosynthesis of the IR precursor in the en-
doplasmic reticulum. This interaction, which triggers de-
phosphorylation of tyrosyl residues of the IR precursor in the
absence of insulin binding, regulates the IR precursor during
its biosynthesis and may be important to prevent insulin-
independent autonomous activity of the immature IR pre-
cursor. In neonatal hepatocytes, if the lack of PTP1B prevents
IR precursor dephosphorylation, this effect might impair IR
processing. The fact that IR expression is down-regulated in
liver extracts and in primary hepatocytes of PTP1B-deficient
FIG. 6. Differential effect of insulin on the activation of PI 3-kinase effectors in immortalized wild-type and PTP1B/ neonatal hepatocytes.
Quiescent cells (15 h serum starved) were stimulated with 10 nM insulin for 1 min to 8 h or maintained in the absence of the hormone. Cells
were then lysed and total protein (50 g) was submitted to SDS-PAGE and analyzed by immunoblotting with the corresponding antibodies
against phospho-Akt, total Akt, phospho-S6K1, phospho-GSK3-(/), and phospho-Foxo1. A representative experiment is shown. The auto-
radiograms corresponding to three experiments, performed in three independent cell lines from each genotype, were quantitated by scanning
densitometry. The value of nonstimulated PTP1B/ and PTP1B/ cells was set to 1. Results are expressed as fold increase by insulin of Akt,
Foxo1, S6K1, andGSK3 phosphorylation and aremeans SE. Statistical significancewas carried out by Student’s t test comparing immortalized
PTP1B/ neonatal hepatocytes with the respective values of wild-type cells. *, P  0.05 was considered significant.
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neonates reinforces our data in immortalized neonatal hepa-
tocytes. However, further studies will be needed to address
this important issue. Additionally, as discussed subse-
quently, we found that endogenous levels of IRS-1 were
increased in neonatal immortalized and primary hepatocytes
lacking PTP1B, whereas IRS-2 expression was down-regu-
lated. Similar changes were also observed in livers of PTP1B-
deficient neonates.
Regarding insulin signaling, our experiments demonstrate
that in contrast to the adult liver, the lack of PTP1B substan-
tially prolongs phosphorylation of IR -chain, IRS-1, and
IRS-2 in immortalized neonatal hepatocytes compared with
wild-type cells (Figs. 3–5) but does not increase insulin sen-
sitivity (Fig. 2A). It is noteworthy that in PTP1B/ neonatal
hepatocytes, there is an increase in basal tyrosine phosphor-
ylation of IRS-1 and IRS-2, which is associated with a de-
tectable basal PI 3-kinase activity. However, the increase in
basal signaling is not due to increased IGF-IR expression or
increased basal tyrosine phosphorylation of IGF-IR in im-
mortalized neonatal PTP1B-deficient hepatocytes. Thus, the
lack of PTP1B might modulate the basal state by increasing
basal tyrosine phosphorylation of IRS proteins. Consistent
with this, the net increase in PI 3-kinase activity after insulin
stimulation is higher in wild-type than in PTP1B/ cells.
Nevertheless, tyrosine phosphorylation of IRS-1 and IRS-2
was prolonged in PTP1B/ neonatal hepatocytes in parallel
to the association with p85/PI 3-kinase and, subsequently,
activation of its enzymatic activity. These results suggest
that, at least in neonatal hepatocytes, a sustained IRS-1,-2/PI
3-kinase signaling could be more important for insulin-reg-
ulated gene expression than the net increase during the first
5–10 min.
Downstream of PI 3-kinase, phosphorylation of Akt is a
critical step in controlling metabolic actions elicited by in-
sulin. Despite the lack of insulin sensitivity in the early steps
of the insulin signaling cascade, the current study reveals
that basal Akt phosphorylation and the insulin response at
low doses are augmented in neonatal hepatocytes lacking
PTP1B. Our results are in agreement with those reported by
Shimizu et al. (34) indicating that a serial activation of the
FIG. 7. Effects of PTP1B rescue in insulin signaling of immortalized PTP1B-deficient neonatal hepatocytes. A, Immortalized PTP1B-deficient
neonatal hepatocytes were reconstituted with retroviral PTP1B as described in Materials and Methods. PTP1B expression in four different cell
lines was assessed byWestern blot. B, Reconstituted hepatocytes (PTP1B/Rec) or PTP1B/ hepatocytes infectedwith empty retroviral vector
(PTP1B/Hygro) were serum starved for 15 h and further stimulated with 10 nM insulin for various time periods. At the end of the culture
time, cells were lysed and 1 mg of total protein was immunoprecipitated with anti-IR -chain antibody. The resulting immune complexes were
analyzed by Western blotting with anti-Tyr(P) or anti-IR antibodies as indicated in each panel. Representative autoradiograms are shown.
Phosphorylation of Akt was assessed by direct Western blot. The autoradiograms corresponding to three experiments, performed in three
independent cell lines from each genotype, were quantitated by scanning densitometry. The value of nonstimulated PTP1B/Rec and
PTP1B/Hygro cells was set to 1. Results are expressed as fold increase by insulin of phosphorylated IR andAkt and aremeans SE. Statistical
significancewas carried out by Student’s t test comparing immortalized PTP1B/Rec hepatocyteswith the respective values of PTP1B/Hygro
cells. *, P  0.05 was considered significant.
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PTP1B/PP2A axis might modulate Akt phosphorylation in
an insulin-dependent (low doses) and -independent (basal
state) manner. However, we cannot exclude the possibility
that other targets of this phosphatase could also regulate
activation of Akt in hepatocytes. Nevertheless, it is notewor-
thy that PTP1B deficiency in neonatal hepatocytes prolonged
the insulin effect on Akt phosphorylation and its down-
stream targets GSK-3, Foxo1, and S6K1. It has been proposed
that phosphorylation and inactivation of GSK-3 serves as a
physiologically relevant mechanism for activating glycogen
synthase (41). In addition, Foxo1 is phosphorylated in an
insulin-responsive manner by Akt and then excluded from
the nucleus (42–44). Previous studies in hepatoma cells sug-
gest that Foxo1 and Foxo3 regulate the transcription of re-
porter genes containing insulin response elements from the
PEPCK and G6Pase promoters (45, 46). Of note, it has been
demonstrated very recently that Foxo proteins promote he-
patic glucose production through multiple mechanisms,
thereby exerting a pivotal role in the metabolic regulation of
the adaptation to fasting and feeding in the liver (47). Indeed,
insulin signaling through Akt/Foxo1 has been shown to
inhibit the expression of the coactivator PGC-1, which is
induced in the liver in the fasting state and in various mouse
models deficient for insulin action and is required for the
expression of PEPCK and G6Pase (48). Thus, the prolonged
phosphorylation of Akt/Foxo1 may have metabolic conse-
quences in the regulation of gluconeogenic gene expression
in PTP1B/ neonatal hepatocytes.
The molecular consequences on insulin signaling pro-
voked by PTP1B deficiency in neonatal hepatocytes have
been validated by two different approaches. First, rescue of
PTP1B in deficient cells suppressed the prolonged insulin
signaling. Second, reduction of PTP1B by two different
siRNA oligos in wild-type cells prolonged signaling similar
to our observations in PTP1B-deficient cell lines. Collectively,
these results indicate that the lack of PTP1B in neonatal
hepatocytes prolongs the insulin effect on IR/IRS-1,-2/PI
3-kinase/Akt/Foxo1 signaling, which results in a sustained
activation of downstream proteins that control insulin’s met-
abolic actions in the liver.
Suppression of glucose output is a critical mechanism of
hepatic insulin sensitivity. Another unexpected finding in
this study was the fact that PTP1B deficiency in neonatal
hepatocytes did not decrease the dose at which insulin down-
regulated PEPCK and G6Pase mRNAs despite the slight
effect of PTP1B deletion on the enhanced response of Akt
FIG. 8. Effects on insulin signaling of siRNA-mediated suppression of PTP1B in wild-type cells. A, Wild-type cells were electroporated with
scrambled or PTP1B specific siRNAs. After 48 h, total lysates were prepared in Laemmli buffer, resolved by SDS-PAGE, and immunoblotted
with antibodies against PTP1B or -actin as a loading control. The autoradiograms corresponding to four independent experiments were
quantitated by scanning densitometry. The value of PTP1B content in cells electroporated with scrambled oligo was set to 100%. Results are
expressed as percentage of decrease of PTP1B in cells electroporated with siRNA oligos and are means  SE. Statistical analysis was carried
out by Student’s t test comparing cells treated with PTP1B siRNA oligos with the respective values of cells treated with scrambled oligo (*, P
0.05). B, Wild-type cells were electroporated with scrambled or PTP1B specific siRNAs. After 48 h, cells were serum starved and further
stimulated with 10 nM insulin for various time periods. Total lysates were prepared in Laemmli buffer, resolved by SDS-PAGE, and immu-
noblotted with specific antibodies. These experiments were repeated twice with each siRNA oligo.
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phosphorylation at low insulin concentrations. Moreover,
we have not found differences in the time course of inhibition
of gluconeogenic enzymes on insulin treatment. However,
the prolonged IR/IRS-1,-2/PI3-kinase/Akt/Foxo1 signaling
of PTP1B/ neonatal hepatocytes was accompanied by a
prolonged inhibitory effect of insulin on PEPCK and G6Pase
mRNAs. In addition, phosphorylation of GSK-3, which was
prolonged in the absence of PTP1B, could also regulate glu-
coneogenic gene expression through the inactivation of tran-
scription factors such as CCAAT/enhancer-binding protein
 or cAMP response element binding protein, which have
potent stimulatory effects on PEPCK gene transcription (49).
Of note, the restoration of PEPCK and G6Pase mRNAs after
long insulin treatment in wild-type cells did not correlate
with an increase in PTP1B content (data not shown). Thus,
the agreement of our signaling and gluconeogenic gene ex-
pression data in neonatal hepatocytes indicate that in these
cells, the effect of PTP1B deletion is manifested by prolonged
insulin action rather than in higher short-term responses.
As mentioned previously, the overall results presented in
this study challenge recently published findings regarding
insulin action in livers of adult PTP1B-deficient mice (26).
Our data indicate that, in PTP1B-deficient mice, there is a
switch from prolonged insulin action to enhanced insulin
sensitivity in a postnatal developmental manner. One pos-
sible molecular explanation for our hypothesis is the devel-
opmental changes in the expression profile of key proteins
that control insulin signaling (i.e. IR, IRS-1,-2, p85), which
might regulate the transition from prolonged insulin action
to increased insulin sensitivity in liver of PTP1B-deficient
mice. In fact, reduced expression of IR in the liver and hepa-
tocytes of PTP1B-deficient neonates compared with the wild
type was not observed in adult mice. It is possible that, at this
stage of development, other tyrosine phosphatases might
compensate the lack of PTP1B, allowing IR precursor de-
phosphorylation and processing like in wild-type hepato-
cytes. More importantly, the significant down-regulation of
IRS-2 in neonatal PTP1B-deficient hepatocytes compared
with the wild type was not observed in adult PTP1B-deficient
hepatocytes. As IRS-2 mediates PI phosphate (PIP)3/Akt
signaling in hepatocytes (11), its recovery in adult PTP1B-
deficient hepatocytes may contribute to the gain of insulin
FIG. 9. Prolonged inhibition by insulin of dex/cAMP-induced PEPCK and G6Pase gene expression in primary PTP1B-deficient neonatal
hepatocytes. A, Primary hepatocytes, obtained from a pool of 3.5- to 5-d-old mice, were cultured to confluence as described in Materials and
Methods. Then, cells were cultured in serum-free medium for 6 to 8 h and further stimulated with dex/cAMP as described in Fig. 2. Then, insulin
(10 nM) was added for 30 min to 3.5 h. At the end of the culture time, RNAwas isolated and submitted to Northern blot analysis. Representative
autoradiograms are shown. The autoradiograms corresponding to four independent experiments were quantitated by scanning densitometry.
The value of dex/cAMP-treated cells was set to 100%. Results are expressed as percentage of decrease by insulin of PEPCK and G6Pase mRNAs
and are means  SE. B, Primary neonatal hepatocytes were cultured as described previously. Insulin (10 nM) was added for 12 to 36 h. At the
end of the culture time, RNA was isolated, submitted to Northern blot analysis, and hybridized with labeled PEPCK and G6Pase cDNAs.
Representative autoradiograms are shown. The autoradiograms corresponding to four independent experiments were quantitated by scanning
densitometry. The value of dex/cAMP-treated cells was set to 100%. Results are expressed as percentage of decrease by insulin of PEPCK and
G6Pase mRNAs and are means  SE. Statistical significance was carried out by Student’s t test comparing primary PTP1B/ neonatal
hepatocytes with the respective values of wild-type cells. *, P  0.05 was considered significant.
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sensitization as occurs in suppressor of cytokine signal-
ing1/ mice (50). In contrast to IR and IRS-2 expression,
IRS-1 is highly expressed in the livers and hepatocytes of
PTP1B-deficient neonates, but its expression decreased in the
adult (data not shown). Preliminary studies in our laboratory
indicate that PTP1B-deficient neonates have a slight but sig-
nificant increase in liver weight compared with wild-type
neonates. Given that IRS-1 signaling mediates somatic
growth and development (51), the up-regulation of IRS-1 in
the livers of PTP1B-deficient neonates might be responsible
for this phenotype. Finally, another possible explanation for
the differences in insulin sensitivity between neonatal and
adult PTP1B-deficient hepatocytes is the p85 regulatory
subunit of PI 3-kinase. During recent years, significant evi-
dence has accumulated indicating that changes in the mo-
lecular balance between the regulatory subunit and the cat-
alytic subunit may affect the PI 3-kinase-dependent signaling
and insulin sensitivity. Thus, p85 can play a dual role in
insulin action mediating PI 3-kinase activation by bridging
IRS proteins and the catalytic p110 subunit but can also act
as a competitive inhibitor in PI 3-kinase signaling in its mo-
nomeric state. Interestingly, p85/mice exhibited increased
insulin sensitivity (52) and display an increase in Akt in
livers. This appears to be due to an improved stoichiometry
of the p85/p110/IRS complex and enhanced PI 3-kinase-
dependent signaling. Our data clearly demonstrate that al-
though p85 expression was significantly down-regulated in
the liver of adult PTP1B-deficient mice, this effect does not
FIG. 10. The expression profile of key molecules of the insulin signaling cascade in PTP1B/ adult liver confers insulin sensitivity in
hepatocytes. A, Lysates from six to eight adult livers from PTP1B/ and PTP1B/ genotypes were analyzed by Western blot with antibodies
against insulin signaling molecules. Representative autoradiograms corresponding to liver extracts from one mouse are shown. The autora-
diograms showing p85 expression from six to eight animals were quantitated by scanning densitometry. Results are expressed as percentage
of decrease of p85 content in PTP1B/ liver extracts compared with the wild type (set to 100%) and are means  SE. Statistical significance
was carried out by Student’s t test comparing PTP1B/ livers with the respective values of the wild type. *, P 0.05 was considered significant.
B, Quiescent primary hepatocytes, isolated from three adult wild-type (PTP1B/) and PTP1B/ mice, were stimulated with various doses
of insulin for 10 min or maintained untreated. Cells were lysed and total protein (50 g) was submitted to SDS-PAGE and analyzed by
immunoblotting with the corresponding antibodies against phospho-Akt (ser473), total Akt, phospho-GSK3, and phospho-Foxo1 (ser256).
Representative autoradiograms corresponding to primary hepatocytes isolated from one animal are shown. The autoradiograms corresponding
to the experiments performed in hepatocytes isolated from three separate mice from each genotype were quantitated by scanning densitometry.
The value of nonstimulated cells was set to 1. Results are expressed as fold increase by insulin of Akt, Foxo1, and GSK-3 phosphorylation and
are means SE. Statistical significance was carried out by Student’s t test comparing primary PTP1B/ adult hepatocytes with the respective
values of wild-type cells. *, P  0.05 was considered significant. C, Primary hepatocytes obtained from adult mice were cultured as described
in Materials and Methods. Then, cells were cultured in serum-free medium for 12 to 15 h and further stimulated with dex/cAMP as described
in Fig. 2. Then, insulin (10 nM) was added for a further 6 h. At the end of the culture time, RNA was isolated and submitted to Northern blot
analysis. Representative autoradiograms corresponding to primary hepatocytes isolated from one mouse are shown. The autoradiograms
corresponding to the experiments performed in hepatocytes isolated from three separate mice from each genotype were quantitated by scanning
densitometry. The value of dex/cAMP-treated cells was set to 100%. Results are expressed as percentage of decrease by insulin of PEPCK and
G6Pase mRNAs and are means  SE. Statistical significance was carried out by Student’s t test comparing PTP1B/ adult hepatocytes with
the respective values of wild-type cells. *, P  0.05 was considered significant.
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occur just after birth. Indeed, insulin sensitivity was ob-
served in primary hepatocytes from adult PTP1B-deficient
mice in Akt signaling and, of note, in the inhibition of glu-
coneogenic gene expression.
In conclusion, the results presented in this paper demon-
strate a direct effect of PTP1B deficiency in prolongation of
insulin signaling and inhibition of gluconeogenic gene ex-
pression in neonatal hepatocytes without significant changes
in insulin sensitivity. During postnatal development of the
liver of PTP1B-deficient mice, changes in the expression of IR
and IRS-2 together with the establishment of a molecular
balance between the regulatory (p85) and the catalytic sub-
units of PI 3-kinase in the liver of PTP1B-deficient mice may
mediate a switch from prolonged insulin action (neonatal
hepatocytes) to the acquisition of insulin sensitivity (adult
hepatocytes). Consequently, inhibition of PTP1B has differ-
ent effects on insulin signaling and gluconeogenic gene ex-
pression depending on the stage of liver development. How-
ever, cross talk between insulin target tissues may contribute
to hepatic insulin action after birth or in adult animals and
should not be excluded.
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